mesogens (separated by one, two, and three spacers),
respectively, have been reported. These studies have dem-
onstrated to an extent that by varying the chemical nature
Scheme 1. Synthesis of Key Intermediates 3a,b
(functionality) of the constituent mesogens, as well as the
length and parity of the spacer, a range of invaluable LOLCs
6
b-e
exhibiting remarkable phase behavior, can be obtained.
In fact, truly multifunctional LCs are the higher oligomers
as they offer an elegant and innovative way of adding various
requisite components. In addition, the organization of these
giant molecules in the mesophase, appear to be rather
intriguing.6 Despite such attractive features, the synthetic
study has been limited to trimers and tetramers of sym-
metrical and nonsymmetrical types. In particular, investiga-
tions on the nonsymmetrical materials, in which the chemical
nature of the constituent anisometric segments is different,
have been scarcely reported. Surprisingly, the synthetic
approaches to higher LOLCs, namely, pentamers, hexamers,
etc. of any kind have not been, to our knowledge, reported
hitherto. This can be ascribed to their immiscibility in organic
d-f
7
solvents, making these LOLCs hard to purify. Owing to their
intrinsic structural diversity, the cumbersome synthetic
pathways are necessary, which perhaps also impede their
growth. Another important factor is that such designs may
not support LC behavior.
Here we report the first successful endeavor of design and
synthesis of mesomorphic, as well as soluble, giant pentamers
composed of five mesogenic segments interlinked through
four flexible spacers varying in their length and parity. The
design is considered to provide functional diversity and
maximize the probability of mesophase formation. In par-
bromoalkanes led to bromides 9a,b, which reacted with 4,4′-
dihydroxybiphenyl in excess to obtain 8a,b. These phenols
were converted to 7a,b. Finally, pentamers 1a,b and 2a,b
were obtained in almost excellent yieds by reacting 7a,b with
3a,b and 7a,b with 4,4′-dihydroxyazobenzene, respectively.
All the intermediates were thoroughly purified by column
chromatography, while the pentamers were purified by
repeated recrystallization in hot DMF. The pentamers were
found to be readily soluble in some of the common organic
solvents. The UV-visible spectrum, of 1a,b showed absorp-
tion maxima at 318 and 355-358 nm, while 2a,b showed
ticular, two sets of both nonsymmetric, 1a,b, and C
symmetric, 2a,b, pentamers have been synthesized. The
2
6f,g
1
13
pentamers 2a,b comprise tolane (half-disc), biphenyl (pro-
an absorption maximum at 360 nm. The H and C NMR
mesogenic,),2 azobenzene (photoactive) mesogenic cores;
a
8
whereas pentamers 1a,b contain cholesterol (chiral, pro-
9
mesogenic, thermochromic,) and naphthalene (mesogenic,
Scheme 2. Synthesis of Precursors 7a,b and Target Pentamers
kinked)10 entities, additionally. The synthesis of pentamers
1a,b and 2a,b required the preparation of key precursors 3a,b
and 7a,b. Schemes 1 and 2 illustrate the synthesis of these
as well as target molecules. Williamson ether synthesis
11
protocol was used for all the transformations. Cholesteryl
6g
ω-bromoalkanoates (6a,b), were reacted with 3-fold excess
of 2,6-dihydroxynaphthalene to obtain monofunctionalized
naphthols 5a,b, which, on refluxing with ∝ ,ω-dibromoal-
kanes, yielded monobromides 4a,b. Treatment of 4,4′-
dihydroxyazobenzene6g in large excess with 4a,b furnished
3
a,b. Scheme 1 depicts the above-mentioned reaction
sequences. As shown in Scheme 2, the condensation of
diphenylacetylene (tolane) 10,6g with 3-fold excess of di-
(
7) For example, several linear pentamers prepared earlier in our
laboratory were found to be insoluble solids with very high melting points.
8) (a) Ikeda, T.; Sasaki, T.; Iehimura. K. Nature 1993, 361, 428. (b)
(
Shishido, A.; Tsutsumi, O.; Kanazawa, A.; Shino, T.; Ikeda, T.; Tamai, N.
J. Am. Chem. Soc. 1997, 117, 7791. (c) Mallia, A.V.; Tamaoki, N. Chem.
Commun. 2004, 2538. (d) Nair, G. G.; Krishna Prasad, S.; Yelamaggad, C.
V. J. Appl. Phys. 2000, 87, 2084.
(
9) (a) Tamaoki, N. AdV. Mater. 2001, 13, 1135. (b) Mallia, A. V.;
Tamaoki, N. Chem. Soc. ReV. 2004, 33, 76.
10) (a) Lauk, U. H.; Skrabal, P.; Zollinger, H. HelV. Chim. Acta 1985,
8, 1406. (b) Duffy, W. L.; Jones, J. L.; Kelly, S. M.; Minter, V.; Tuffin,
R. Mol. Cryst. Liq. Cryst. 1999, 332, 91.
11) See Supporting Information for details.
(
6
(
2642
Org. Lett., Vol. 9, No. 14, 2007